{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:23:47Z","timestamp":1793723027921,"version":"4.6.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"8112","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2026,4,30]]},"DOI":"10.1038\/s41586-026-10143-0","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:02:32Z","timestamp":1771430552000},"page":"1329-1338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The integrated stress response promotes immune evasion through lipocalin 2"],"prefix":"10.1038","volume":"652","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2101-2863","authenticated-orcid":false,"given":"Jozef P.","family":"Bossowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8335-3463","authenticated-orcid":false,"given":"Ray","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4685-3314","authenticated-orcid":false,"given":"Angela","family":"Wong Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rashidfarrokhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0472-0166","authenticated-orcid":false,"given":"Katherine","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5502-2595","authenticated-orcid":false,"given":"Takamitsu","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1371-4980","authenticated-orcid":false,"given":"Eliezra","family":"Glasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1796-7077","authenticated-orcid":false,"given":"Akiko","family":"Koide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre L.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Hajdu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahith","family":"Rajalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"LeBoeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hortense","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6791-8296","authenticated-orcid":false,"given":"Seungeun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3545-5481","authenticated-orcid":false,"given":"Jin Woo","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheolyong","family":"Joe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyemin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Young","family":"Ock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9219-3350","authenticated-orcid":false,"given":"Se-Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angana A. H.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5225-8260","authenticated-orcid":false,"given":"Volkan I.","family":"Sayin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7512-8477","authenticated-orcid":false,"given":"Aristotelis","family":"Tsirigos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6323-235X","authenticated-orcid":false,"given":"Kwok-Kin","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4843-3791","authenticated-orcid":false,"given":"Sergei B.","family":"Koralov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7864-8937","authenticated-orcid":false,"given":"Mario","family":"Pende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8466-8563","authenticated-orcid":false,"given":"Francisco J.","family":"S\u00e1nchez-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane M.","family":"Simeone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2386-9553","authenticated-orcid":false,"given":"Ioannis K.","family":"Zervantonakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5473-4358","authenticated-orcid":false,"given":"Shohei","family":"Koide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2251-1624","authenticated-orcid":false,"given":"Thales","family":"Papagiannakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"10143_CR1","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.15252\/embr.201642195","volume":"17","author":"K Pakos-Zebrucka","year":"2016","unstructured":"Pakos-Zebrucka, K. et al. The integrated stress response. EMBO Rep. 17, 1374\u20131395 (2016).","journal-title":"EMBO Rep."},{"key":"10143_CR2","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41556-019-0347-9","volume":"21","author":"F Tameire","year":"2019","unstructured":"Tameire, F. et al. ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progression. Nat. Cell Biol. 21, 889\u2013899 (2019).","journal-title":"Nat. Cell Biol."},{"key":"10143_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccell.2017.12.003","volume":"33","author":"DM Gwinn","year":"2018","unstructured":"Gwinn, D. M. et al. Oncogenic KRAS regulates amino acid homeostasis and asparagine biosynthesis via ATF4 and alters sensitivity to l-asparaginase. Cancer Cell 33, 91\u2013107 (2018).","journal-title":"Cancer Cell"},{"key":"10143_CR4","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.ccell.2018.03.018","volume":"33","author":"MD Hellmann","year":"2018","unstructured":"Hellmann, M. D. et al. Genomic features of response to combination immunotherapy in patients with advanced non-small-cell lung cancer. Cancer Cell 33, 843\u2013852 (2018).","journal-title":"Cancer Cell"},{"key":"10143_CR5","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.1200\/JCO.23.01136","volume":"41","author":"R Seth","year":"2023","unstructured":"Seth, R. et al. Systemic therapy for melanoma: ASCO guideline update. J. Clin. Oncol. 41, 4794\u20134820 (2023).","journal-title":"J. Clin. Oncol."},{"key":"10143_CR6","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1002\/cam4.4703","volume":"11","author":"DJ Benjamin","year":"2022","unstructured":"Benjamin, D. J., Haslam, A., Gill, J. & Prasad, V. Targeted therapy in lung cancer: are we closing the gap in years of life lost?. Cancer Med. 11, 3417\u20133424 (2022).","journal-title":"Cancer Med."},{"key":"10143_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.799455","volume":"12","author":"C Genova","year":"2021","unstructured":"Genova, C. et al. Therapeutic implications of tumor microenvironment in lung cancer: focus on immune checkpoint blockade. Front. Immunol. 12, 799455 (2021).","journal-title":"Front. Immunol."},{"key":"10143_CR8","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","volume":"8","author":"Global Burden of Disease 2019 Cancer Collaboration.","year":"2022","unstructured":"Global Burden of Disease 2019 Cancer Collaboration. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. JAMA Oncol. 8, 420\u2013444 (2022).","journal-title":"JAMA Oncol."},{"key":"10143_CR9","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1200\/JCO.19.01207","volume":"37","author":"D Rangachari","year":"2019","unstructured":"Rangachari, D. & Costa, D. B. From hope to reality: durable overall survival with immune checkpoint inhibitors for advanced lung cancer. J. Clin. Oncol. 37, 2511\u20132513 (2019).","journal-title":"J. Clin. Oncol."},{"key":"10143_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13046-020-01824-3","volume":"40","author":"M Akman","year":"2021","unstructured":"Akman, M. et al. Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons. J. Exp. Clin. Cancer Res. 40, 28 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10143_CR11","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.cell.2016.12.004","volume":"168","author":"JR Cubillos-Ruiz","year":"2017","unstructured":"Cubillos-Ruiz, J. R., Bettigole, S. E. & Glimcher, L. H. Tumorigenic and immunosuppressive effects of endoplasmic reticulum stress in cancer. Cell 168, 692\u2013706 (2017).","journal-title":"Cell"},{"key":"10143_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.devcel.2020.06.018","volume":"54","author":"F Li","year":"2020","unstructured":"Li, F. & Simon, M. C. Cancer cells don\u2019t live alone: metabolic communication within tumor microenvironments. Dev. Cell 54, 183\u2013195 (2020).","journal-title":"Dev. Cell"},{"key":"10143_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/febs.14359","volume":"286","author":"J Obacz","year":"2019","unstructured":"Obacz, J. et al. Regulation of tumor\u2013stroma interactions by the unfolded protein response. FEBS J. 286, 279\u2013296 (2019).","journal-title":"FEBS J."},{"key":"10143_CR14","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/s41556-022-00918-8","volume":"24","author":"II Verginadis","year":"2022","unstructured":"Verginadis, I. I. et al. A stromal integrated stress response activates perivascular cancer-associated fibroblasts to drive angiogenesis and tumour progression. Nat. Cell Biol. 24, 940\u2013953 (2022).","journal-title":"Nat. Cell Biol."},{"key":"10143_CR15","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1038\/emboj.2010.81","volume":"29","author":"J Ye","year":"2010","unstructured":"Ye, J. et al. The GCN2\u2013ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. EMBO J. 29, 2082\u20132096 (2010).","journal-title":"EMBO J."},{"key":"10143_CR16","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1038\/onc.2012.439","volume":"32","author":"S Bhattacharya","year":"2013","unstructured":"Bhattacharya, S. et al. Anti-tumorigenic effects of type 1 interferon are subdued by integrated stress responses. Oncogene 32, 4214\u20134221 (2013).","journal-title":"Oncogene"},{"key":"10143_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aar2036","volume":"10","author":"HG Nguyen","year":"2018","unstructured":"Nguyen, H. G. et al. Development of a stress response therapy targeting aggressive prostate cancer. Sci. Transl. Med. 10, eaar2036 (2018).","journal-title":"Sci. Transl. Med."},{"key":"10143_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24661-0","volume":"12","author":"N Ghaddar","year":"2021","unstructured":"Ghaddar, N. et al. The integrated stress response is tumorigenic and constitutes a therapeutic liability in KRAS-driven lung cancer. Nat. Commun. 12, 4651 (2021).","journal-title":"Nat. Commun."},{"key":"10143_CR19","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.cmet.2021.02.001","volume":"33","author":"AS Krall","year":"2021","unstructured":"Krall, A. S. et al. Asparagine couples mitochondrial respiration to ATF4 activity and tumor growth. Cell Metab. 33, 1013\u20131026 (2021).","journal-title":"Cell Metab."},{"key":"10143_CR20","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41586-023-06464-z","volume":"620","author":"J Li","year":"2023","unstructured":"Li, J. et al. Non-cell-autonomous cancer progression from chromosomal instability. Nature 620, 1080\u20131088 (2023).","journal-title":"Nature"},{"key":"10143_CR21","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.69015","volume":"10","author":"B De Ponte Conti","year":"2021","unstructured":"De Ponte Conti, B. et al. mTOR-dependent translation drives tumor infiltrating CD8+ effector and CD4+ Treg cells expansion. eLife 10, e69015 (2021).","journal-title":"eLife"},{"key":"10143_CR22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.molcel.2020.10.031","volume":"81","author":"AF Zyryanova","year":"2021","unstructured":"Zyryanova, A. F. et al. ISRIB blunts the integrated stress response by allosterically antagonising the inhibitory effect of phosphorylated eIF2 on eIF2B. Mol. Cell 81, 88\u2013103 (2021).","journal-title":"Mol. Cell"},{"key":"10143_CR23","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR\u2013Cas9. Nat. Biotechnol. 34, 184\u2013191 (2016).","journal-title":"Nat. Biotechnol."},{"key":"10143_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.tem.2017.01.003","volume":"28","author":"AR Moschen","year":"2017","unstructured":"Moschen, A. R., Adolph, T. E., Gerner, R. R., Wieser, V. & Tilg, H. Lipocalin-2: a master mediator of intestinal and metabolic inflammation. Trends Endocrinol. Metab. 28, 388\u2013397 (2017).","journal-title":"Trends Endocrinol. Metab."},{"key":"10143_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s43018-023-00519-w","volume":"4","author":"O Adler","year":"2023","unstructured":"Adler, O. et al. Reciprocal interactions between innate immune cells and astrocytes facilitate neuroinflammation and brain metastasis via lipocalin-2. Nat. Cancer 4, 401\u2013418 (2023).","journal-title":"Nat. Cancer"},{"key":"10143_CR26","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03104","volume":"432","author":"TH Flo","year":"2004","unstructured":"Flo, T. H. et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432, 917\u2013921 (2004).","journal-title":"Nature"},{"key":"10143_CR27","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41416-019-0655-7","volume":"122","author":"C Rehwald","year":"2020","unstructured":"Rehwald, C. et al. The iron load of lipocalin-2 (LCN-2) defines its pro-tumour function in clear-cell renal cell carcinoma. Br. J. Cancer 122, 421\u2013433 (2020).","journal-title":"Br. J. Cancer"},{"key":"10143_CR28","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1021\/cb200331g","volume":"6","author":"TM Hoette","year":"2011","unstructured":"Hoette, T. M. et al. Immune interference in Mycobacterium tuberculosis intracellular iron acquisition through siderocalin recognition of carboxymycobactins. ACS Chem. Biol. 6, 1327\u20131331 (2011).","journal-title":"ACS Chem. Biol."},{"key":"10143_CR29","doi-asserted-by":"publisher","first-page":"14058","DOI":"10.1073\/pnas.0710846105","volume":"105","author":"A Iannetti","year":"2008","unstructured":"Iannetti, A. et al. The neutrophil gelatinase-associated lipocalin (NGAL), a NF-\u03baB-regulated gene, is a survival factor for thyroid neoplastic cells. Proc. Natl Acad. Sci. USA 105, 14058\u201314063 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10143_CR30","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.3390\/cancers13164210","volume":"13","author":"S Tillmann","year":"2021","unstructured":"Tillmann, S. et al. The unfolded protein response is a major driver of LCN2 expression in BCR\u2013ABL- and JAK2V617F-positive MPN. Cancers 13, 4210 (2021).","journal-title":"Cancers"},{"key":"10143_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10330","volume":"7","author":"K El Karoui","year":"2016","unstructured":"El Karoui, K. et al. Endoplasmic reticulum stress drives proteinuria-induced kidney lesions via lipocalin 2. Nat. Commun. 7, 10330 (2016).","journal-title":"Nat. Commun."},{"key":"10143_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02599-4","volume":"20","author":"J Wen","year":"2022","unstructured":"Wen, J. et al. Efficacy of metformin therapy in patients with cancer: a meta-analysis of 22 randomised controlled trials. BMC Med. 20, 402 (2022).","journal-title":"BMC Med."},{"key":"10143_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adm9859","volume":"10","author":"R Pillai","year":"2024","unstructured":"Pillai, R. et al. Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer. Sci. Adv. 10, eadm9859 (2024).","journal-title":"Sci. Adv."},{"key":"10143_CR34","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nri3920","volume":"15","author":"Y Lavin","year":"2015","unstructured":"Lavin, Y., Mortha, A., Rahman, A. & Merad, M. Regulation of macrophage development and function in peripheral tissues. Nat. Rev. Immunol. 15, 731\u2013744 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"10143_CR35","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrc.2016.54","volume":"16","author":"C Engblom","year":"2016","unstructured":"Engblom, C., Pfirschke, C. & Pittet, M. J. The role of myeloid cells in cancer therapies. Nat. Rev. Cancer 16, 447\u2013462 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"10143_CR36","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41586-021-03651-8","volume":"595","author":"M Casanova-Acebes","year":"2021","unstructured":"Casanova-Acebes, M. et al. Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells. Nature 595, 578\u2013584 (2021).","journal-title":"Nature"},{"key":"10143_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy, R. & Pollard, J. W. Tumor-associated macrophages: from mechanisms to therapy. Immunity 41, 49\u201361 (2014).","journal-title":"Immunity"},{"key":"10143_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40425-019-0504-5","volume":"7","author":"JJ Miret","year":"2019","unstructured":"Miret, J. J. et al. Suppression of myeloid cell arginase activity leads to therapeutic response in a NSCLC mouse model by activating anti-tumor immunity. J. Immunother. Cancer 7, 32 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"10143_CR39","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.cell.2020.07.013","volume":"182","author":"M Molgora","year":"2020","unstructured":"Molgora, M. et al. TREM2 modulation remodels the tumor myeloid landscape enhancing anti-PD-1 immunotherapy. Cell 182, 886\u2013900 (2020).","journal-title":"Cell"},{"key":"10143_CR40","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1126\/science.ade2292","volume":"381","author":"R Bill","year":"2023","unstructured":"Bill, R. et al. CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers. Science 381, 515\u2013524 (2023).","journal-title":"Science"},{"key":"10143_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adi1501","volume":"16","author":"M Czech","year":"2024","unstructured":"Czech, M. et al. Lipocalin-2 expression identifies an intestinal regulatory neutrophil population during acute graft-versus-host disease. Sci. Transl. Med. 16, eadi1501 (2024).","journal-title":"Sci. Transl. Med."},{"key":"10143_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.exphem.2019.05.001","volume":"74","author":"A Hermann","year":"2019","unstructured":"Hermann, A. et al. Lipocalin-2 levels in acute and chronic graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Exp. Hematol. 74, 25\u201332 (2019).","journal-title":"Exp. Hematol."},{"key":"10143_CR43","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1172\/JCI67911","volume":"123","author":"JM Warszawska","year":"2013","unstructured":"Warszawska, J. M. et al. Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes. J. Clin. Invest. 123, 3363\u20133372 (2013).","journal-title":"J. Clin. Invest."},{"key":"10143_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27452-9","volume":"12","author":"F Yao","year":"2021","unstructured":"Yao, F. et al. A targetable LIFR-NF-\u03baB\u2013LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis. Nat. Commun. 12, 7333 (2021).","journal-title":"Nat. Commun."},{"key":"10143_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/srep35014","volume":"6","author":"T Toyonaga","year":"2016","unstructured":"Toyonaga, T. et al. Lipocalin 2 prevents intestinal inflammation by enhancing phagocytic bacterial clearance in macrophages. Sci. Rep. 6, 35014 (2016).","journal-title":"Sci. Rep."},{"key":"10143_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101420","volume":"5","author":"L Wang","year":"2024","unstructured":"Wang, L. et al. PD-L1-expressing tumor-associated macrophages are immunostimulatory and associate with good clinical outcome in human breast cancer. Cell Rep. Med. 5, 101420 (2024).","journal-title":"Cell Rep. Med."},{"key":"10143_CR47","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.7150\/ijbs.79915","volume":"19","author":"HS An","year":"2023","unstructured":"An, H. S. et al. Lipocalin-2 promotes acute lung inflammation and oxidative stress by enhancing macrophage iron accumulation. Int. J. Biol. Sci. 19, 1163\u20131177 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"10143_CR48","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","volume":"26","author":"IG House","year":"2020","unstructured":"House, I. G. et al. Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade. Clin. Cancer Res. 26, 487\u2013504 (2020).","journal-title":"Clin. Cancer Res."},{"key":"10143_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26407-4","volume":"12","author":"EH Bent","year":"2021","unstructured":"Bent, E. H. et al. Microenvironmental IL-6 inhibits anti-cancer immune responses generated by cytotoxic chemotherapy. Nat. Commun. 12, 6218 (2021).","journal-title":"Nat. Commun."},{"key":"10143_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3834","volume":"4","author":"V Byles","year":"2013","unstructured":"Byles, V. et al. The TSC\u2013mTOR pathway regulates macrophage polarization. Nat. Commun. 4, 2834 (2013).","journal-title":"Nat. Commun."},{"key":"10143_CR51","doi-asserted-by":"publisher","unstructured":"Rashidfarrokhi, A. et al. Tumor-intrinsic LKB1\u2013LIF signaling axis establishes a myeloid niche to promote immune evasion and tumor growth. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.07.15.549147 (2023).","DOI":"10.1101\/2023.07.15.549147"},{"key":"10143_CR52","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.jtho.2020.06.001","volume":"15","author":"AL Moreira","year":"2020","unstructured":"Moreira, A. L. et al. A grading system for invasive pulmonary adenocarcinoma: a proposal from the International Association for the Study of Lung Cancer Pathology Committee. J. Thorac. Oncol. 15, 1599\u20131610 (2020).","journal-title":"J. Thorac. Oncol."},{"key":"10143_CR53","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.3390\/cancers16193353","volume":"16","author":"JE Hwang","year":"2024","unstructured":"Hwang, J.-E. et al. Tumor immune microenvironment biomarkers for recurrence prediction in locally advanced rectal cancer patients after neoadjuvant chemoradiotherapy. Cancers 16, 3353 (2024).","journal-title":"Cancers"},{"key":"10143_CR54","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/bph.16257","volume":"181","author":"B Gyorffy","year":"2024","unstructured":"Gy\u0151rffy, B. Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer. Br. J. Pharmacol. 181, 362\u2013374 (2024).","journal-title":"Br. J. Pharmacol."},{"key":"10143_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113295","volume":"42","author":"AM Zavitsanou","year":"2023","unstructured":"Zavitsanou, A. M. et al. KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance. Cell Rep. 42, 113295 (2023).","journal-title":"Cell Rep."},{"key":"10143_CR56","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","volume":"163","author":"LD Wood","year":"2022","unstructured":"Wood, L. D., Canto, M. I., Jaffee, E. M. & Simeone, D. M. Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment. Gastroenterology 163, 386\u2013402 (2022).","journal-title":"Gastroenterology"},{"key":"10143_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36296-4","volume":"14","author":"G Werba","year":"2023","unstructured":"Werba, G. et al. Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment. Nat. Commun. 14, 797 (2023).","journal-title":"Nat. Commun."},{"key":"10143_CR58","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1210\/me.2014-1092","volume":"28","author":"H Guo","year":"2014","unstructured":"Guo, H., Jin, D. & Chen, X. Lipocalin 2 is a regulator of macrophage polarization and NF-\u03baB\/STAT3 pathway activation. Mol. Endocrinol. 28, 1616\u20131628 (2014).","journal-title":"Mol. Endocrinol."},{"key":"10143_CR59","doi-asserted-by":"publisher","first-page":"e1009487","DOI":"10.1371\/journal.ppat.1009487","volume":"17","author":"ML Watzenboeck","year":"2021","unstructured":"Watzenboeck, M. L. et al. Lipocalin 2 modulates dendritic cell activity and shapes immunity to influenza in a microbiome dependent manner. PLoS Pathog. 17, e1009487 (2021).","journal-title":"PLoS Pathog."},{"key":"10143_CR60","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1164\/rccm.202004-1079OC","volume":"203","author":"W Treekitkarnmongkol","year":"2021","unstructured":"Treekitkarnmongkol, W. et al. Augmented lipocalin-2 Is associated with chronic obstructive pulmonary disease and counteracts lung adenocarcinoma development. Am. J. Respir. Crit. Care Med. 203, 90\u2013101 (2021).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10143_CR61","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41586-024-08285-0","volume":"637","author":"X Zhuang","year":"2025","unstructured":"Zhuang, X. et al. Ageing limits stemness and tumorigenesis by reprogramming iron homeostasis. Nature 637, 184\u2013194 (2025).","journal-title":"Nature"},{"key":"10143_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089497","volume":"9","author":"G La Manna","year":"2014","unstructured":"La Manna, G. et al. Neutrophil gelatinase-associated lipocalin increases HLA-G+\/FoxP3+ T-regulatory cell population in an in vitro model of PBMC. PLoS ONE\u00a09, e89497 (2014).","journal-title":"PLoS ONE"},{"key":"10143_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108542","volume":"33","author":"F Mimoto","year":"2020","unstructured":"Mimoto, F. et al. Exploitation of elevated extracellular ATP to specifically direct antibody to tumor microenvironment. Cell Rep. 33, 108542 (2020).","journal-title":"Cell Rep."},{"key":"10143_CR64","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau3259","volume":"11","author":"J Ishihara","year":"2019","unstructured":"Ishihara, J. et al. Targeted antibody and cytokine cancer immunotherapies through collagen affinity. Sci. Transl. Med. 11, eaau3259 (2019).","journal-title":"Sci. Transl. Med."},{"key":"10143_CR65","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006682","volume":"5","author":"LR Desnoyers","year":"2013","unstructured":"Desnoyers, L. R. et al. Tumor-specific activation of an EGFR-targeting probody enhances therapeutic index. Sci. Transl. Med. 5, 207ra144 (2013).","journal-title":"Sci. Transl. Med."},{"key":"10143_CR66","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/nm.4407","volume":"23","author":"R Romero","year":"2017","unstructured":"Romero, R. et al. Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis. Nat. Med. 23, 1362\u20131368 (2017).","journal-title":"Nat. Med."},{"key":"10143_CR67","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abk1023","volume":"7","author":"H Ding","year":"2021","unstructured":"Ding, H. et al. Activation of the NRF2 antioxidant program sensitizes tumors to G6PD inhibition. Sci. Adv. 7, eabk1023 (2021).","journal-title":"Sci. Adv."},{"key":"10143_CR68","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cmet.2019.11.012","volume":"31","author":"SE LeBoeuf","year":"2020","unstructured":"LeBoeuf, S. E. et al. Activation of oxidative stress response in cancer generates a druggable dependency on exogenous non-essential amino acids. Cell Metab. 31, 339\u2013350 (2020).","journal-title":"Cell Metab."},{"key":"10143_CR69","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.cell.2019.06.003","volume":"178","author":"L Lignitto","year":"2019","unstructured":"Lignitto, L. et al. Nrf2 activation promotes lung cancer metastasis by inhibiting the degradation of Bach1. Cell 178, 316\u2013329 (2019).","journal-title":"Cell"},{"key":"10143_CR70","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.28083","volume":"6","author":"VI Sayin","year":"2017","unstructured":"Sayin, V. I. et al. Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer. eLife 6, e28083 (2017).","journal-title":"eLife"},{"key":"10143_CR71","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature13906","volume":"516","author":"FJ Sanchez-Rivera","year":"2014","unstructured":"S\u00e1nchez-Rivera, F. J. et al. Rapid modelling of cooperating genetic events in cancer through somatic genome editing. Nature 516, 428\u2013431 (2014).","journal-title":"Nature"},{"key":"10143_CR72","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1158\/2159-8290.CD-22-0416","volume":"13","author":"YM Soto-Feliciano","year":"2023","unstructured":"Soto-Feliciano, Y. M. et al. A molecular switch between mammalian MLL complexes dictates response to menin\u2013MLL inhibition. Cancer Discov. 13, 146\u2013169 (2023).","journal-title":"Cancer Discov."},{"key":"10143_CR73","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/nbt.3026","volume":"32","author":"JG Doench","year":"2014","unstructured":"Doench, J. G. et al. Rational design of highly active sgRNAs for CRISPR\u2013Cas9-mediated gene inactivation. Nat. Biotechnol. 32, 1262\u20131267 (2014).","journal-title":"Nat. Biotechnol."},{"key":"10143_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 15, 554 (2014).","journal-title":"Genome Biol."},{"key":"10143_CR75","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41592-019-0392-0","volume":"16","author":"EP Mimitou","year":"2019","unstructured":"Mimitou, E. P. et al. Multiplexed detection of proteins, transcriptomes, clonotypes and CRISPR perturbations in single cells. Nat. Methods 16, 409\u2013412 (2019).","journal-title":"Nat. Methods"},{"key":"10143_CR76","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nmeth.4380","volume":"14","author":"M Stoeckius","year":"2017","unstructured":"Stoeckius, M. et al. Simultaneous epitope and transcriptome measurement in single cells. Nat. Methods 14, 865\u2013868 (2017).","journal-title":"Nat. Methods"},{"key":"10143_CR77","doi-asserted-by":"publisher","DOI":"10.21105\/joss.00861","volume":"3","author":"L McInnes","year":"2018","unstructured":"McInnes, L., Healy, J., Saul, N. & Gro\u00dfberger, L. UMAP: uniform manifold approximation and projection. J. Open Source Softw. 3, 861 (2018).","journal-title":"J. Open Source Softw."},{"key":"10143_CR78","doi-asserted-by":"publisher","first-page":"e43746","DOI":"10.1371\/journal.pone.0043746","volume":"7","author":"KR Miller","year":"2012","unstructured":"Miller, K. R. et al. Tcell receptor-like recognition of tumor in vivo by synthetic antibody fragment. PLoS ONE\u00a07, e43746 (2012).","journal-title":"PLoS ONE"},{"key":"10143_CR79","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41586-021-03672-3","volume":"595","author":"J Oury","year":"2021","unstructured":"Oury, J. et al. Mechanism of disease and therapeutic rescue of Dok7 congenital myasthenia. Nature 595, 404\u2013408 (2021).","journal-title":"Nature"},{"key":"10143_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2020.112952","volume":"490","author":"T Hattori","year":"2020","unstructured":"Hattori, T. et al. Multiplex bead binding assays using off-the-shelf components and common flow cytometers. J. Immunol. Methods 490, 112952 (2020).","journal-title":"J. Immunol. Methods"},{"key":"10143_CR81","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2319029121","volume":"121","author":"L Maso","year":"2024","unstructured":"Maso, L. et al. Molecular basis for antibody recognition of multiple drug\u2013peptide\/MHC complexes. Proc. Natl Acad. Sci. USA 121, e2319029121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10143_CR82","doi-asserted-by":"crossref","unstructured":"Igarashi, T. et al. Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines. Oncogene 26, 4749\u20134760 (2007).","DOI":"10.1038\/sj.onc.1210289"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10143-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10143-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10143-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:06:44Z","timestamp":1777464404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10143-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":82,"journal-issue":{"issue":"8112","published-print":{"date-parts":[[2026,4,30]]}},"alternative-id":["10143"],"URL":"https:\/\/doi.org\/10.1038\/s41586-026-10143-0","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"13 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.P. received funding from Pfizer Medical Education Group, Dracen Pharmaceuticals, Kymera Therapeutics, Bristol Myers Squibb and Agios Pharmaceuticals, not related to the submitted work. S.K. is a co-founder\u00a0of, receives consulting fees from and holds equity in Aethon Therapeutics; is a co-founder of\u00a0and holds equity in Revalia Bio; and has received research funding from Aethon Therapeutics, Argenx BVBA, Black Diamond Therapeutics and Puretech Health, all outside of the current work. S.B.K. has previously received funding from Micreos, BMS and Kymera Therapeutics. T.P., S.K., J.P.B. and J.K. are listed as inventors on a patent application (PCT\/US24\/19489: \u2018Anti-lipocalin-2 antibodies and uses thereof\u2019).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}